137 related articles for article (PubMed ID: 25562108)
1. Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro.
Van den Hof WF; Ruiz-Aracama A; Van Summeren A; Jennen DG; Gaj S; Coonen ML; Brauers K; Wodzig WK; van Delft JH; Kleinjans JC
Toxicol In Vitro; 2015 Apr; 29(3):489-501. PubMed ID: 25562108
[TBL] [Abstract][Full Text] [Related]
2. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
[TBL] [Abstract][Full Text] [Related]
3. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
4. Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.
Van Summeren A; Renes J; Lizarraga D; Bouwman FG; Noben JP; van Delft JH; Kleinjans JC; Mariman EC
OMICS; 2013 Feb; 17(2):71-83. PubMed ID: 23308384
[TBL] [Abstract][Full Text] [Related]
5. Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.
Van Summeren A; Renes J; Bouwman FG; Noben JP; van Delft JH; Kleinjans JC; Mariman EC
Toxicol Sci; 2011 Mar; 120(1):109-22. PubMed ID: 21163907
[TBL] [Abstract][Full Text] [Related]
6. A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen.
Driessen M; Vitins AP; Pennings JL; Kienhuis AS; Water Bv; van der Ven LT
Toxicol Lett; 2015 Jan; 232(2):403-12. PubMed ID: 25448281
[TBL] [Abstract][Full Text] [Related]
7. Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices.
Vatakuti S; Pennings JL; Gore E; Olinga P; Groothuis GM
Chem Res Toxicol; 2016 Mar; 29(3):342-51. PubMed ID: 26881866
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis.
Kienhuis AS; Vitins AP; Pennings JL; Pronk TE; Speksnijder EN; Roodbergen M; van Delft JH; Luijten M; van der Ven LT
Toxicol Lett; 2013 Aug; 221(3):225-36. PubMed ID: 23830897
[TBL] [Abstract][Full Text] [Related]
9. Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach.
Vatakuti S; Olinga P; Pennings JLA; Groothuis GMM
Arch Toxicol; 2017 Mar; 91(3):1401-1412. PubMed ID: 27344345
[TBL] [Abstract][Full Text] [Related]
10. Integration of transcriptomics and metabolomics profiling reveals the metabolic pathways affected in dictamnine-induced hepatotoxicity in mice.
Li ZQ; Wang LL; Zhou J; Zheng X; Jiang Y; Li P; Li HJ
J Proteomics; 2020 Feb; 213():103603. PubMed ID: 31812602
[TBL] [Abstract][Full Text] [Related]
11. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
Zhang A; Sun H; Wang P; Han Y; Wang X
Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
[TBL] [Abstract][Full Text] [Related]
12. Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis.
Wolters JE; van Herwijnen MH; Theunissen DH; Jennen DG; Van den Hof WF; de Kok TM; Schaap FG; van Breda SG; Kleinjans JC
Chem Res Toxicol; 2016 Dec; 29(12):2164-2174. PubMed ID: 27989131
[TBL] [Abstract][Full Text] [Related]
13. Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models.
Schmeits PC; Schaap MM; Luijten M; van Someren E; Boorsma A; van Loveren H; Peijnenburg AA; Hendriksen PJ
Arch Toxicol; 2015 Dec; 89(12):2325-37. PubMed ID: 25224403
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
[TBL] [Abstract][Full Text] [Related]
15. Classification of hepatotoxicants using HepG2 cells: A proof of principle study.
Van den Hof WF; Coonen ML; van Herwijnen M; Brauers K; Wodzig WK; van Delft JH; Kleinjans JC
Chem Res Toxicol; 2014 Mar; 27(3):433-42. PubMed ID: 24437676
[TBL] [Abstract][Full Text] [Related]
16. Omics-based identification of the combined effects of idiosyncratic drugs and inflammatory cytokines on the development of drug-induced liver injury.
Jiang J; Mathijs K; Timmermans L; Claessen SM; Hecka A; Weusten J; Peters R; van Delft JH; Kleinjans JCS; Jennen DGJ; de Kok TM
Toxicol Appl Pharmacol; 2017 Oct; 332():100-108. PubMed ID: 28733206
[TBL] [Abstract][Full Text] [Related]
17. Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes.
Adler M; Leich E; Ellinger-Ziegelbauer H; Hewitt P; Dekant W; Rosenwald A; Mally A
Toxicology; 2014 Dec; 326():86-95. PubMed ID: 25456269
[TBL] [Abstract][Full Text] [Related]
18. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.
Parmentier C; Couttet P; Wolf A; Zaccharias T; Heyd B; Bachellier P; Uteng M; Richert L
Arch Toxicol; 2017 Aug; 91(8):2879-2893. PubMed ID: 28188341
[TBL] [Abstract][Full Text] [Related]
20. An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid.
Peng S; Yan L; Zhang J; Wang Z; Tian M; Shen H
J Pharm Biomed Anal; 2013 Dec; 86():56-64. PubMed ID: 23978341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
